ACLT WEBINAR | New Sickle Cell Gene Editing Therapy: Q&A
Join Sickle Cell Warriors, Clinicians, and ACLT exploring the advancements in gene editing therapy and answering your questions.
Join us on Wednesday 19th March for an insightful and informative ACLT webinar exploring the new era of ground-breaking advancements in gene editing therapy for sickle cell disorder (SCD). This event will bring together leading experts, researchers, patients (warriors), donors and healthcare professionals to discuss the latest innovations in CRISPR (pronounced “crisper”) an acronym for Clustered Regularly Interspaced Short Palindromic Repeats, which is a technology that allows scientists to alter the DNA of living organisms and its transformative potential for individuals affected by SCD. It is based on a bacterial defence system that protects against viruses.
Sign Up Here
